{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T20:49:36Z","timestamp":1771879776980,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd007450","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,11,27]],"date-time":"2014-11-27T00:00:00Z","timestamp":1417046400000}}],"reference-count":31,"publisher":"Wiley","issue":"11","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007450.pub2","type":"journal-article","created":{"date-parts":[[2014,11,27]],"date-time":"2014-11-27T07:27:55Z","timestamp":1417073275000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Blood pressure lowering efficacy of partial agonist beta blocker monotherapy for primary hypertension"],"prefix":"10.1002","volume":"2014","author":[{"given":"Gavin WK","family":"Wong","sequence":"first","affiliation":[{"name":"University of British Columbia; Department of Anesthesiology, Pharmacology and Therapeutics; 2176 Health Sciences Mall Vancouver BC Canada V6T 1Z3"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi N","family":"Boyda","sequence":"additional","affiliation":[{"name":"University of British Columbia; Department of Anesthesiology, Pharmacology and Therapeutics; 2176 Health Sciences Mall Vancouver BC Canada V6T 1Z3"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James M","family":"Wright","sequence":"additional","affiliation":[{"name":"University of British Columbia; Department of Anesthesiology, Pharmacology and Therapeutics; 2176 Health Sciences Mall Vancouver BC Canada V6T 1Z3"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,11,27]]},"reference":[{"key":"10.1002\/14651858.CD007450.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"650","DOI":"10.5694\/j.1326-5377.1976.tb140941.x","article-title":"Double blind factorial trial of pindolol and hydrochlorothiazide in hypertension","volume":"1","author":"Chalmer","year":"1976","journal-title":"Medical Journal of Australia"},{"key":"10.1002\/14651858.CD007450.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF00545213","article-title":"Effect of once daily indapamide and pindolol on blood pressure, plasma aldosterone concentration and plasma renin activity in a general practice setting","volume":"22","author":"Chalmers","year":"1982","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD007450.pub2-BIB0003|cit3","first-page":"2881","article-title":"The treatment of hypertension in elderly using a beta-blocker: acebutolol.","volume":"8","author":"Forette","year":"1979","journal-title":"Nouvelle Presse M\u00e9dicale"},{"key":"10.1002\/14651858.CD007450.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF00645127","article-title":"Controlled trial of acebutolol in hypertension","volume":"12","author":"Hansson","year":"1977","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD007450.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1472-8206.1988.tb01008.x","article-title":"Bopindolol in the treatment of moderate hypertension: a dose response study","volume":"2","author":"Moleur","year":"1988","journal-title":"Fundamental & Clinical Pharmacology"},{"key":"10.1002\/14651858.CD007450.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF00616411","article-title":"Hypotensive effect of oxprenolol in mild to moderate hypertension: a multicentre controlled study","volume":"8","author":"Motolese","year":"1975","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD007450.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1080\/14017430600801675","article-title":"Effect of celiprolol and simvastatin on the calculated risk of coronary heart disease","volume":"40","author":"Olkinuora","year":"2006","journal-title":"Scandinavian Cardiovascular Journal"},{"key":"10.1002\/14651858.CD007450.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1185\/03007997909109451","article-title":"Placebo-controlled, double blind clinical trial of alprenolol in Afraican hypertensive patients","volume":"6","author":"Salako","year":"1979","journal-title":"Current Medical Research and Opinion"},{"key":"10.1002\/14651858.CD007450.pub2-BIB0009|cit9","first-page":"73","article-title":"A comparison of celiprolol and atenolol in the treatment of hypertension: A placebo controlled double blind study","volume":"Spp 40","author":"Stump","year":"1985","journal-title":"British Journal of Clinical Practice"},{"key":"10.1002\/14651858.CD007450.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.0954-6820.1969.tb01502.x","article-title":"Antihypertensive therapy with alprenolol, a beta-adrenergic receptor antagonist","volume":"186","author":"Tibblin","year":"1969","journal-title":"Acta Medica Scandinavica"},{"key":"10.1002\/14651858.CD007450.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1185\/03007998909112671","article-title":"A multi-centre, placebo controlled comparative study between 200 mg and 400 mg celiprolol in patients with mild to moderate essential hypertension","volume":"11","author":"Trafford","year":"1989","journal-title":"Current Medical Research and Opinion"},{"key":"10.1002\/14651858.CD007450.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1365-2125.1986.tb05226.x","article-title":"Plasma catecholamines following exercise in hypertensives treated with pindolol: comparison with placebo and metoprolol","volume":"21","author":"Vandongen","year":"1986","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD007450.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2125.1980.tb05835.x","article-title":"Comparison of once and twice daily administration of acebutolol in hypertension","volume":"9","author":"Watson","year":"1980","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD007450.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1055\/s-2008-1047714","article-title":"A double-blind placebo-controlled comparison of the effects of beta receptor blockers and ACE inhibitor on renal haemodynamics and proteinuria in chronic glomerulonephritis","volume":"122","author":"Erley","year":"1997","journal-title":"Deutsche Medizinische Wochenschrift"},{"key":"10.1002\/14651858.CD007450.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1185\/03007998609110429","article-title":"Acebutolol in the treatment of diabetic patients with hypertension","volume":"10","author":"Fraser","year":"1986","journal-title":"Current Medical Research and Opinion"},{"key":"10.1002\/14651858.CD007450.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1365-2125.1984.tb02356.x","article-title":"The psychological side effects of acebutolol and atenolol","volume":"17","author":"Lewis","year":"1984","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"1","key":"10.1002\/14651858.CD007450.pub2-BIB0017|cit17","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007185.pub2","article-title":"Blood pressure lowering efficacy of beta-blockers as second-line therapy for primary hypertension","author":"Chen","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD007450.pub2-BIB0018|cit18","unstructured":"Canadian Pharmacist Association https:\/\/www.e-therapeutics.ca\/cps.showMonograph.action Accessd on OCT 2012"},{"key":"10.1002\/14651858.CD007450.pub2-BIB0019|cit19","unstructured":"European Electronic Medical Compendium http:\/\/www.medicines.org.uk\/emc\/default.aspx Date accessed MAY 2013"},{"key":"10.1002\/14651858.CD007450.pub2-BIB0020|cit20","unstructured":"FDA Online Label Repository http:\/\/labels.fda.gov\/ Accessed on MAY 2013"},{"issue":"4","key":"10.1002\/14651858.CD007450.pub2-BIB0021|cit21","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003823.pub2","article-title":"Blood pressure lowering efficacy of angiotensin converting enzyme(ACE) inhibitors for primary hypertension","author":"Heran","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD007450.pub2-BIB0022|cit22","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003822.pub2","article-title":"Blood pressure lowering efficacy of angiotensin receptor blockers for primary hypertension","author":"Heran","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD007450.pub2-BIB0023|cit23","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD007450.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: Is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD007450.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1161\/CIRCULATIONAHA.104.529628","article-title":"Headaches and the treatment of blood pressure results from a meta-analysis of 94 randomized placebo-controlled trials with 24 000 participants","volume":"112","author":"Law","year":"2005","journal-title":"Circulation"},{"issue":"1","key":"10.1002\/14651858.CD007450.pub2-BIB0026|cit26","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002863","article-title":"Oral beta-blockers for mild to moderate hypertension during pregnancy","author":"Magee","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD007450.pub2-BIB0027|cit27","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002003.pub4","article-title":"Beta-blockers for hypertension","author":"Wiysonge","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD007450.pub2-BIB0028|cit28","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007449","article-title":"Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension","author":"Wong","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD007450.pub2-BIB0029|cit29","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007451","article-title":"Blood pressure lowering efficacy of beta-1 selective beta blockers for primary hypertension","author":"Wong","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD007450.pub2-BIB0030|cit30","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007452.pub2","article-title":"Blood pressure lowering efficacy of nonselective beta-blockers for primary hypertension","author":"Wong","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD007450.pub2-BIB0031|cit31","first-page":"188","article-title":"Choosing a first-line drug in the management of elevated blood pressure: What is the evidence? 2: \u03b2-Blockers","volume":"163","author":"Wright","year":"2000","journal-title":"CMAJ"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD007450.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T04:47:02Z","timestamp":1698295622000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD007450.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Hypertension Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,11,27]]},"references-count":31,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2014,11]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007450.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,27]]}}}